News

A new, injectable form of pembrolizumab has been rolled out on the NHS, cutting the time of treatment by up to 90%.

Semaglutide improved motivation in patients with major depressive disorder, holding promise for the treatment of neuropsychiatric disorders characterised by reward dysfunction.

Researchers collated an updated record of male infertility risk factors in a 2026 umbrella review.

In this latest study, researchers showed that while the ketogenic diet maintained intestinal balance under normal conditions, it significantly exacerbated colitis when the gut lining was damaged.

Organ transplant cryopreservation may be influenced by solution properties, with higher glass transition temperatures linked to reduced tissue damage in experimental models.

CRISPR gene therapy shows improved haemoglobin levels and reduced vaso occlusive events in severe sickle cell disease in early phase study data.

COVID-19 disrupted melanoma diagnoses, reducing early detection and shifting prognostic patterns across regions with different public health strategies.

Large phase 3 trial involving over 300 patients with active lupus, those treated with obinutuzumab achieved markedly higher response rates at one year. Nearly 77% of patients receiving the therapy met the primary endpoint